Knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers - a cross-sectional study.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
15 Jan 2019
Historique:
received: 16 04 2018
accepted: 07 01 2019
entrez: 17 1 2019
pubmed: 17 1 2019
medline: 20 2 2019
Statut: epublish

Résumé

Antibiotic resistance is a global health threat. Public knowledge is considered a prerequisite for appropriate use of antibiotics and limited spread of antibiotic resistance. Our aim was to examine the level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, and to assess to which degree beliefs, attitudes and sociodemographic factors are associated with this knowledge. A questionnaire based, cross-sectional study was conducted among pharmacy customers in three Norwegian cities. The questionnaire covered 1) knowledge of antibiotics (13 statements) and antibiotic resistance (10 statements), 2) the general beliefs about medicines questionnaire (BMQ general) (three subdomains, four statements each), 3) attitudes toward antibiotic use (four statements), and 4) sociodemographic factors, life style and health. High knowledge level was defined as > 66% of maximum score. Factors associated with knowledge of antibiotics and antibiotic resistance were investigated through univariate and multiple linear regression. Hierarchical model regression was used to estimate a population average knowledge score weighted for age, gender and level of education. Among 877 participants, 57% had high knowledge of antibiotics in general and 71% had high knowledge of antibiotic resistance. More than 90% knew that bacteria can become resistant against antibiotics and that unnecessary use of antibiotics can make them less effective. Simultaneously, more than 30% erroneously stated that antibiotics are effective against viruses, colds or influenza. Factors positively associated with antibiotic knowledge were health professional background, high education level, and a positive view on the value of medications in general. Male gender, a less restrictive attitude toward antibiotic use, and young age were negatively associated with antibiotic knowledge. The mean overall antibiotic knowledge score was relatively high (15.6 out of maximum 23 with estimated weighted population score at 14.8). Despite a high level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, there are obvious knowledge gaps. We suggest that action is taken to increase the knowledge level, and particularly target people in vocational, male dominated occupations outside the health service, and primary/secondary school curricula.

Sections du résumé

BACKGROUND BACKGROUND
Antibiotic resistance is a global health threat. Public knowledge is considered a prerequisite for appropriate use of antibiotics and limited spread of antibiotic resistance. Our aim was to examine the level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, and to assess to which degree beliefs, attitudes and sociodemographic factors are associated with this knowledge.
METHODS METHODS
A questionnaire based, cross-sectional study was conducted among pharmacy customers in three Norwegian cities. The questionnaire covered 1) knowledge of antibiotics (13 statements) and antibiotic resistance (10 statements), 2) the general beliefs about medicines questionnaire (BMQ general) (three subdomains, four statements each), 3) attitudes toward antibiotic use (four statements), and 4) sociodemographic factors, life style and health. High knowledge level was defined as > 66% of maximum score. Factors associated with knowledge of antibiotics and antibiotic resistance were investigated through univariate and multiple linear regression. Hierarchical model regression was used to estimate a population average knowledge score weighted for age, gender and level of education.
RESULTS RESULTS
Among 877 participants, 57% had high knowledge of antibiotics in general and 71% had high knowledge of antibiotic resistance. More than 90% knew that bacteria can become resistant against antibiotics and that unnecessary use of antibiotics can make them less effective. Simultaneously, more than 30% erroneously stated that antibiotics are effective against viruses, colds or influenza. Factors positively associated with antibiotic knowledge were health professional background, high education level, and a positive view on the value of medications in general. Male gender, a less restrictive attitude toward antibiotic use, and young age were negatively associated with antibiotic knowledge. The mean overall antibiotic knowledge score was relatively high (15.6 out of maximum 23 with estimated weighted population score at 14.8).
CONCLUSIONS CONCLUSIONS
Despite a high level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, there are obvious knowledge gaps. We suggest that action is taken to increase the knowledge level, and particularly target people in vocational, male dominated occupations outside the health service, and primary/secondary school curricula.

Identifiants

pubmed: 30646892
doi: 10.1186/s12889-019-6409-x
pii: 10.1186/s12889-019-6409-x
pmc: PMC6332570
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

66

Références

Acta Psychiatr Scand. 2009 Jan;119(1):78-84
pubmed: 18983630
J Med Internet Res. 2015 Aug 13;17(8):e193
pubmed: 26272267
Pharm World Sci. 2010 Feb;32(1):97-102
pubmed: 19921545
Tidsskr Nor Laegeforen. 2009 Dec 17;129(24):2610-2
pubmed: 20029557
PLoS One. 2016 Apr 20;11(4):e0152160
pubmed: 27096751
Tidsskr Nor Laegeforen. 2011 Apr 8;131(7):680-3
pubmed: 21494302
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3035-3039
pubmed: 28265082
Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1234-43
pubmed: 17879325
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
J Antimicrob Chemother. 2007 May;59(5):971-6
pubmed: 17329270
PLoS One. 2013 Dec 23;8(12):e84177
pubmed: 24376793
J Antimicrob Chemother. 2010 Jun;65(6):1292-6
pubmed: 20360063
Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):2-10
pubmed: 25251203
J Am Board Fam Med. 2010 Mar-Apr;23(2):159-65
pubmed: 20207925
J Antimicrob Chemother. 2016 Jan;71(1):27-33
pubmed: 26459555
J Antimicrob Chemother. 2017 Apr 1;72(4):975-987
pubmed: 27999058
Patient Educ Couns. 2018 Apr;101(4):679-686
pubmed: 29249596

Auteurs

Marit Waaseth (M)

Department of Pharmacy, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromsø, Norway. marit.waaseth@uit.no.

Abdifatah Adan (A)

Department of Pharmacy, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromsø, Norway.

Ingrid L Røen (IL)

Department of Global Public Health and Primary Care, University of Bergen, PO Box 7804, N-5020, Bergen, Norway.

Karoline Eriksen (K)

Department of Global Public Health and Primary Care, University of Bergen, PO Box 7804, N-5020, Bergen, Norway.

Tijana Stanojevic (T)

Pharmacoepidemiology and Drug Safety Research Group, School of Pharmacy, University of Oslo, PO Box 1068 Blindern, N-0316, Oslo, Norway.

Kjell H Halvorsen (KH)

Department of Pharmacy, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromsø, Norway.

Beate H Garcia (BH)

Department of Pharmacy, UiT The Arctic University of Norway, PO Box 6050 Langnes, N-9037, Tromsø, Norway.

Lone Holst (L)

Department of Global Public Health and Primary Care, University of Bergen, PO Box 7804, N-5020, Bergen, Norway.

Karen M Ulshagen (KM)

Norwegian Medicines Agency, PO Box 6167 Etterstad, N-0602, Oslo, Norway.

Hege S Blix (HS)

Division of Mental and Physical Health, Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403, Oslo, Norway.

Hilde Ariansen (H)

Pharmacoepidemiology and Drug Safety Research Group, School of Pharmacy, University of Oslo, PO Box 1068 Blindern, N-0316, Oslo, Norway.

Hedvig M E Nordeng (HME)

Pharmacoepidemiology and Drug Safety Research Group, School of Pharmacy, University of Oslo, PO Box 1068 Blindern, N-0316, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH